Akari Therapeutics, Plc

AKTXNASDAQHealthcare● Active

$15.28

+$0.21(+1.37%)

Market Cap$17485512

P/E Ratio—

52W High$54

52W Low$3.015

Avg Volume764K

Open$15.08

Beta1.33

Overview

Akari Therapeutics, Plc (AKTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AKTX · as of Mar 30, 2026

Latest filing snapshot

-2-25.00%vs prior year

Akari Therapeutics, Plc (AKTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-2

Growth % (1Y)

-25.00%

Revenue / Employee

—

Net Income / Employee

$-2.88M

Market Cap

$17M

AKTX Employee Count

2012 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-30	2025-12-31	6	-2	-25.00%
2025-04-15	2024-12-31	8	-4	-33.33%
2024-03-29	2023-12-31	12	-3	-20.00%
2023-05-01	2022-12-31	15	+6	+66.67%
2022-05-16	2021-12-31	9	+1	+12.50%
2021-04-21	2020-12-31	8	-2	-20.00%
2020-03-31	2019-12-31	10	-3	-23.08%
2019-04-23	2018-12-31	13	-4	-23.53%
2018-07-18	2017-12-31	17	+2	+13.33%
2017-03-31	2016-12-31	15	+10	+200.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Psyence Biomedical Ltd.

Dermata Therapeutics, Inc.

8$1M #5

REVB

Revelation Biosciences, Inc.

8$4M #6

AKTX

Akari Therapeutics, PlcYOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AKTX peer comparison

About AKTX employees

AKTX Employees · Headcount

Akari Therapeutics, Plc (AKTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Akari Therapeutics, Plc had 6 full-time employees globally. Full-time employees only. Global consolidated headcount.

Akari Therapeutics, Plc's workforce decreased by 2 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AKTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Akari Therapeutics, Plc had 6 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Akari Therapeutics, Plc employee counthow many employees does Akari Therapeutics, Plc haveAKTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30